Bio-Rad Laboratories, Inc.Class A

BIONYSEUSD
319.66 USD
5.20 (1.65%)🟢LIVE (AS OF 03:20 PM EDT)
🟢Market: OPEN

Bio-Rad Laboratories, Inc.Class A (BIO) is currently trading at $319.66. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. On valuation, BIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jul 24, 2026.

Open?$317.37
High?$320.19
Low?$315.86
Prev. Close?$314.46
Volume?151.4K
Avg. Volume?312.8K
VWAP?$318.77
Rel. Volume?0.48x
Bid / Ask
Bid?$319.72 × 80
Ask?$320.11 × 80
Spread?$0.39
Midpoint?$319.92
Valuation & Ratios
Market Cap?8.4B
Shares Out?21.7M
Float?18.1M
Float %?83.4%
P/E Ratio?49.85
P/B Ratio?1.23
EPS?$6.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
8.4B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1980-02-29
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
82
Momentum?
60
Short Sent.?
60
Piotroski F-Score?3/9Weak
Altman Z-Score?3.40Safe
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?8.62%Elevated
Short Interest?1.6M
Days to Cover?6.0
Free Float18.1M
Avg Daily Volume261.6K
Settlement Date2026-07-15
Financial Health
Current Ratio?3.21Strong
Quick Ratio?2.37Strong
Cash Ratio?0.55Adequate
Debt/Equity?0.18Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
61/100
P/E?
Peers
40
S&P
13
49.9PRICEY
P/B?
Peers
90
S&P
93
1.23CHEAP
P/S?
Peers
82
S&P
47
3.25FAIR
P/FCF?
Peers
82
S&P
43
23.6FAIR
EV/EBITDA?
Peers
27
S&P
6
39.6HIGH
EV/Sales?
Peers
82
S&P
53
3.52FAIR
Returns & Efficiency
ROE?
Peers
22
S&P
17
2.5%WEAK
ROA?
Peers
10
S&P
17
1.7%WEAK
Cash Flow & Enterprise
FCF?$357.2M
Enterprise Value?$9.1B
Fundamentals ratios updated end of day